Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab.
Long A, Rahmaoui A, Rothman KJ, Guinan E, Eisner M, Bradley MS, Iribarren C, Chen H, Carrigan G, Rosén K, Szefler SJ.
Long A, et al.
J Allergy Clin Immunol. 2014 Sep;134(3):560-567.e4. doi: 10.1016/j.jaci.2014.02.007. Epub 2014 Mar 27.
J Allergy Clin Immunol. 2014.
PMID: 24679845
Free article.
Clinical Trial.